| Tretinoin | Approved Investigational Nutraceutical | ZNF77 | 58492 |
upregulated | Tretinoin results in increased expression of ZNF77 mRNA | 19p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ZNF788 | 388507 |
downregulated | Tretinoin results in decreased expression of ZNF788 mRNA | 19p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ZNF814 | 730051 |
downregulated | Tretinoin results in decreased expression of ZNF814 mRNA | 19q13.43 | |
| Tretinoin | Approved Investigational Nutraceutical | ZNF826P | 664701 |
downregulated | Tretinoin results in decreased expression of ZNF826P mRNA | 19p12 | |
| Tretinoin | Approved Investigational Nutraceutical | ZNF827 | 152485 |
upregulated | Tretinoin results in increased expression of ZNF827 mRNA | 4q31.21-q31.22 | |
| Tretinoin | Approved Investigational Nutraceutical | ZNF850 | 342892 |
downregulated | Tretinoin results in decreased expression of ZNF850 mRNA | 19q13.12 | |
| Tretinoin | Approved Investigational Nutraceutical | ZNF853 | 54753 |
upregulated | Tretinoin results in increased expression of ZNF853 mRNA | 7p22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ZNF862 | 643641 |
upregulated | Tretinoin results in increased expression of ZNF862 mRNA | 7q36.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ZNF876P | 642280 |
downregulated | Tretinoin results in decreased expression of ZNF876P mRNA | 4p16.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ZNF883 | 169834 |
downregulated | Tretinoin results in decreased expression of ZNF883 mRNA | 9q32 | |
| Tretinoin | Approved Investigational Nutraceutical | ZNRF1 | 84937 |
upregulated | Tretinoin results in increased expression of ZNRF1 mRNA | 16q23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ZP3 | 7784 |
downregulated | Tretinoin results in decreased expression of ZP3 mRNA | 7q11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | ZRANB1 | 54764 |
upregulated | Tretinoin results in increased expression of ZRANB1 mRNA | 10q26.13 | |
| Tretinoin | Approved Investigational Nutraceutical | ZSWIM7 | 125150 |
downregulated | Tretinoin results in decreased expression of ZSWIM7 mRNA | 17p12 | |
| Tretinoin | Approved Investigational Nutraceutical | ZWILCH | 55055 |
downregulated | Tretinoin results in decreased expression of ZWILCH mRNA | 15q22.31 | |
| Tretinoin | Approved Investigational Nutraceutical | ZYG11A | 440590 |
downregulated | Tretinoin results in decreased expression of ZYG11A mRNA | 1p32.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ZYX | 7791 |
upregulated | Tretinoin results in increased expression of ZYX mRNA | 7q34 | |
| Triamcinolone | Approved Investigational Vet Approved | CYP2S1 | 29785 |
downregulated | Triamcinolone Acetonide results in decreased expression of CYP2S1 mRNA | 19q13.2 | |
| Triamcinolone | Approved Investigational Vet Approved | CYP3A5 | 1577 |
upregulated | Triamcinolone Acetonide results in increased expression of CYP3A5 mRNA | 7q22.1 | |
| Tributyrin | Investigational | BCL2 | 596 |
downregulated | tributyrin results in decreased expression of BCL2 mRNA | 18q21.33 | |
| Metrifonate | Experimental Vet Approved | STAR | 6770 |
downregulated | Trichlorfon results in decreased expression of STAR mRNA | 8p11.23 | |
| Triclocarban | Approved | CYP1B1 | 1545 |
upregulated | triclocarban results in increased expression of CYP1B1 mRNA | 2p22.2 | |
| Triclocarban | Approved | CYP2B6 | 1555 |
upregulated | triclocarban results in increased expression of CYP2B6 mRNA | 19q13.2 | |
| Triclocarban | Approved | UGT1A1 | 54658 |
upregulated | triclocarban results in increased expression of UGT1A1 mRNA | 2q37.1 | |
| Triclocarban | Approved | UGT1A3 | 54659 |
upregulated | triclocarban results in increased expression of UGT1A3 mRNA | 2q37.1 | |